Richardson, TX, United States of America

Regina Weaks

This inventor holds 1 USPTO granted patent. Top assignee: Texas A&M University System. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Regina Weaks. Retrieved from https://idiyas.com/inventor/regina-weaks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Regina Weaks

Introduction

Regina Weaks is a notable inventor based in Richardson, TX (US). He has made significant contributions to the field of biotechnology, particularly in the area of nuclear transfer and cloning techniques. His work has implications for both transgenic and non-transgenic mammalian production.

Latest Patents

Regina Weaks holds a patent titled "Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors." This patent provides methods and compositions aimed at increasing the efficiency of nuclear transfer through the use of apoptosis inhibitors. The techniques outlined in this patent facilitate the cloning of mammals and the production of transgenic and chimeric mammalian tissues, as well as chimeric cell lines.

Career Highlights

He is affiliated with the Texas A&M University System, where he continues to advance research in his field. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Regina Weaks has collaborated with esteemed colleagues such as Jorge A Piedrahita and Chang-Kyu Lee. These partnerships have further enriched his research and contributed to the advancement of biotechnological methods.

Conclusion

Regina Weaks is a pioneering inventor whose work in nuclear transfer and cloning techniques has the potential to transform the field of biotechnology. His contributions are vital for the development of new methods in mammalian production and genetic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…